← Back to Search
Dynamic And Cellular Interactions Of Nanoparticles In Vascular-targeted Drug Delivery (review)
R. B. Huang, Supriya Mocherla, M. Heslinga, P. Charoenphol, O. Eniola-Adefeso
Published 2010 · Medicine
Save to my Library
Download PDFAnalyze on Scholarcy
Abstract Vascular-targeted drug delivery systems could provide more efficient and effective pharmaceutical interventions for treating a variety of diseases including cardiovascular, pulmonary, inflammatory, and malignant disorders. However, several factors must be taken into account when designing these systems. The diverse blood hemodynamics and rheology, and the natural clearance process that tend to decrease the circulation time of foreign particles all lessen the probability of successful carrier interaction with the vascular wall. An effective vascular-targeted drug delivery system must be able to navigate through the bloodstream while avoiding immune clearance, attach to the vascular wall, and release its therapeutic cargo at the intended location. This review will summarize and analyze current literature reporting on (1) nanocarrier fabrication methods and materials that allow for optimum therapeutic encapsulation, protection, and release; (2) localization and binding dynamics of nanocarriers as influenced by hemodynamics and blood rheology in medium-to-large vessels; (3) blood cells' responses to various types of nanocarrier compositions and its effects on particle circulation time; and (4) properties that affect nanocarrier internalization at the target site.
This paper references
Role of target geometry in phagocytosis.
J. Champion (2006)
Blood platelets are concentrated near the wall and red blood cells, in the center in flowing blood.
P. Aarts (1988)
Localization to atherosclerotic plaque and biodistribution of biochemically derivatized superparamagnetic iron oxide nanoparticles (SPIONs) contrast particles for magnetic resonance imaging (MRI)
Bryan R. Smith (2008)
S. Bhaskar (2009)
Interaction of PLGA nanoparticles with human blood constituents.
D. Kim (2005)
Spatiotemporal controlled delivery of nanoparticles to injured vasculature
J. M. Chan (2010)
In vivo delivery of a peptide, ghrelin antagonist, with mesoporous silicon microparticles.
M. Kilpeläinen (2009)
Nanomedicine, nanotoxicology: two sides of the same coin
VE Kagan (2005)
The role of the size and number of polyethylene glycol chains in the biodistribution and tumor localization of triazine dendrimers.
Jongdoo Lim (2008)
Single-walled carbon nanotubes activate platelets and accelerate thrombus formation in the microcirculation.
P. Bihari (2010)
Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts
M. Lundqvist (2008)
The effect of PEGylation of mesoporous silica nanoparticles on nonspecific binding of serum proteins and cellular responses.
Q. He (2010)
Cardiac safety profile of prolonged (>or=6 cycles) pegylated liposomal doxorubicin administration in patients with gynecologic malignancies.
D. Uyar (2004)
Highly efficient drug delivery with gold nanoparticle vectors for in vivo photodynamic therapy of cancer.
Yu Cheng (2008)
The release of inflammatory cytokines from human peripheral blood mononuclear cells in vitro following exposure to adenovirus variants and capsid.
J. N. Higginbotham (2002)
Viral nanoparticles associate with regions of inflammation and blood brain barrier disruption during CNS infection
L. Shriver (2009)
Vascular endothelial growth factor selectively targets boronated dendrimers to tumor vasculature
M. Backer (2005)
Liposomes in biology and medicine.
R. Schwendener (2007)
The binding avidity of a nanoparticle-based multivalent targeted drug delivery platform.
Seungpyo Hong (2007)
I-domain of lymphocyte function-associated antigen-1 mediates rolling of polystyrene particles on ICAM-1 under flow.
A. O. Eniola (2005)
Size-dependent internalization of particles via the pathways of clathrin- and caveolae-mediated endocytosis.
J. Rejman (2004)
Nanoparticles evading the reticuloendothelial system: role of the supported bilayer.
Shyh-Dar Li (2009)
Targeted delivery of therapeutics to endothelium
E. Simone (2008)
Atherosclerosis and cancer: common molecular pathways of disease development and progression.
J. Ross (2001)
Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size.
F. Yuan (1995)
Antiangiogenic properties of silver nanoparticles.
S. Gurunathan (2009)
Size-dependent proinflammatory effects of ultrafine polystyrene particles: a role for surface area and oxidative stress in the enhanced activity of ultrafines.
D. Brown (2001)
Inflammatory Diseases of Blood Vessels
G. Hoffman (2001)
Nanoconjugate based on polymalic acid for tumor targeting.
J. Ljubimova (2008)
The release of in fl ammatory cytokines from human peripheral blood mononuclear cells in vitro following exposure to adenovirus variants , capsid
JN Higginbotham (2002)
Tumor-targeted delivery of siRNA by self-assembled nanoparticles.
Shyh-Dar Li (2008)
Exploring polyethylenimine‐mediated DNA transfection and the proton sponge hypothesis
A. Akinc (2005)
In vivo single molecular imaging and sentinel node navigation by nanotechnology for molecular targeting drug-delivery systems and tailor-made medicine
M. Takeda (2008)
Cationic albumin-conjugated pegylated nanoparticles allow gene delivery into brain tumors via intravenous administration.
W. Lu (2006)
Gold nanoparticles and a microscopic view of platelets: a preliminary observation.
V. Wiwanitkit (2009)
A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine.
O. Boussif (1995)
Nitric oxide release in human aortic endothelial cells mediated by delivery of amphiphilic polysiloxane nanoparticles to caveolae.
Takehiro Nishikawa (2009)
Evaluation of effect of charge and lipid coating on ability of 60-nm nanoparticles to cross an in vitro model of the blood-brain barrier.
L. Fenart (1999)
Endocytosis pathways in endothelium: how many?
R. Stan (2006)
Dendrimers and dendritic polymers in drug delivery.
E. Gillies (2005)
Vascular Targeted Nanoparticles for Imaging and Treatment of Brain Tumors
G. R. Reddy (2006)
VCAM-1 directed immunoliposomes selectively target tumor vasculature in vivo.
S. Gosk (2008)
Nanoparticle-mediated simultaneous and targeted delivery of paclitaxel and tariquidar overcomes tumor drug resistance.
Y. Patil (2009)
Diphtheria Toxin Mutant CRM197-Mediated Transcytosis across Blood–Brain Barrier In Vitro
P. Wang (2010)
Mesoporous silicon in drug delivery applications.
J. Salonen (2008)
Fabrication of biodegradable spheroidal microparticles for drug delivery applications.
M. Heslinga (2009)
Direct fabrication and harvesting of monodisperse, shape-specific nanobiomaterials.
J. Rolland (2005)
ICAM-1 recycling in endothelial cells: a novel pathway for sustained intracellular delivery and prolonged effects of drugs.
S. Muro (2005)
Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells.
B. Chithrani (2006)
Shape effects of filaments versus spherical particles in flow and drug delivery.
Y. Geng (2007)
Biodegradable luminescent porous silicon nanoparticles for in vivo applications.
J. Park (2009)
Role of clathrin- and caveolae-mediated endocytosis in gene transfer mediated by lipo- and polyplexes.
J. Rejman (2005)
Polymersomes: tough vesicles made from diblock copolymers.
B. Discher (1999)
Targeting of superoxide dismutase and catalase to vascular endothelium.
V. Muzykantov (2001)
Endothelial Dysfunction, Hemodynamic Forces, and Atherogenesis a
M. Gimbrone (2000)
Tickets to ride: selecting cargo for clathrin-regulated internalization
L. Traub (2009)
The induction of inflammation by adenovirus vectors used for gene therapy.
M. J. Cotter (2005)
The margination propensity of spherical particles for vascular targeting in the microcirculation
F. Gentile (2008)
Factors Affecting the Clearance and Biodistribution of Polymeric Nanoparticles
F. Alexis (2008)
The association of silicon microparticles with endothelial cells in drug delivery to the vasculature.
R. Serda (2009)
The relationship between the antimicrobial effect of catheter coatings containing silver nanoparticles and the coagulation of contacting blood.
K. Stevens (2009)
Targeted single-wall carbon nanotube-mediated Pt(IV) prodrug delivery using folate as a homing device.
S. Dhar (2008)
Platelet aggregation induced by latex particles. I. Effects of size, surface potential and hydrophobicity of particles.
M. Miyamoto (1989)
pH-sensitive polymers that enhance intracellular drug delivery in vivo.
T. Kyriakides (2002)
The hydrogel template method for fabrication of homogeneous nano/microparticles.
G. Acharya (2010)
Effects of nano-scaled particles on endothelial cell function in vitro: Studies on viability, proliferation and inflammation
K. Peters (2004)
Porous silicon in drug delivery devices and materials.
E. Anglin (2008)
The Acute Proinflammatory and Prothrombotic Effects of Pulmonary Exposure to Rutile TiO2 Nanorods in Rats
A. Nemmar (2008)
Endothelial dysfunction, hemodynamic forces
M A Gimbrone (2000)
Structural stabilization in tetrameric or polymeric hemoglobin determines its interaction with endogenous antioxidant scavenger pathways.
P. Buehler (2008)
Influence of PAMAM dendrimers on human red blood cells.
D. Domański (2004)
Molecular Imaging of Inflammation in Atherosclerosis With Targeted Ultrasound Detection of Vascular Cell Adhesion Molecule-1
B. Kaufmann (2007)
Control of endothelial targeting and intracellular delivery of therapeutic enzymes by modulating the size and shape of ICAM-1-targeted carriers.
S. Muro (2008)
Vascular endothelial growth factor-C siRNA delivered via calcium carbonate nanoparticle effectively inhibits lymphangiogenesis and growth of colorectal cancer in vivo.
Xiao-wen He (2009)
Blood platelets are concentrated near the wall, red blood cells
P A Aarts (1988)
Functionalized mesoporous silica nanoparticle-based drug delivery system to rescue acrolein-mediated cell death.
Youngnam Cho (2008)
The effect of particle design on cellular internalization pathways
Stephanie E. A. Gratton (2008)
Endothelial Targeting of Cowpea Mosaic Virus (CPMV) via Surface Vimentin
Kristopher J. Koudelka (2009)
Dynamics of Blood Flow and Platelet Transport in Pathological Vessels
S. Einav (2004)
Localization to atherosclerotic plaque and biodistribution of biochemically derivatized superparamagnetic iron oxide nanoparticles (SPIONs) contrast particles for magnetic resonance imaging (MRI)
Bryan R. Smith (2007)
Characterization of biodegradable drug delivery vehicles with the adhesive properties of leukocytes.
A. O. Eniola (2002)
Water-soluble carbosilane dendrimers: synthesis biocompatibility and complexation with oligonucleotides; evaluation for medical applications.
J. F. Bermejo (2007)
Magnetic control of vascular network formation with magnetically labeled endothelial progenitor cells.
C. Wilhelm (2007)
The vessel wall and its interactions.
D. Wagner (2008)
Silicon and bone health.
R. Jugdaohsingh (2007)
Nutrition, rheumatic disease (nutrition, health)
L. Coleman (2008)
Purification of Bionanoparticles
L. Pedro (2008)
Characterization of antiplatelet properties of silver nanoparticles.
Siddhartha S Shrivastava (2009)
Influence of poly(ethylene glycol) grafting density and polymer length on liposomes: relating plasma circulation lifetimes to protein binding.
N. Dos Santos (2007)
Influence of surface charge and inner composition of porous nanoparticles to cross blood-brain barrier in vitro.
Y. Jallouli (2007)
In vivo photodynamic activity of photosensitizer-loaded nanoparticles: formulation properties, administration parameters and biological issues involved in PDT outcome.
A. Vargas (2008)
Investigations on the toxicological profile of functionalized fifth‐generation poly(propylene imine) dendrimer
H. Agashe (2006)
Biocompatibility of poly(ether)urethane-gold nanocomposites.
S. Hsu (2006)
Targeting atherosclerosis by using modular, multifunctional micelles
D. Peters (2009)
Endothelial targeting of semi-permeable polymer nanocarriers for enzyme therapies.
T. Dziubla (2008)
Virus-based nanoparticles (VNPs): platform technologies for diagnostic imaging.
M. Manchester (2006)
Mesoporous silicon particles as a multistage delivery system for imaging and therapeutic applications.
E. Tasciotti (2008)
Design of bio-mimetic particles with enhanced vascular interaction.
Sei-Young Lee (2009)
In vivo tumor targeting of tumor necrosis factor-alpha-loaded stealth nanoparticles: effect of MePEG molecular weight and particle size.
Chao Fang (2006)
Interaction of Poly(butylcyanoacrylate) Nanoparticles with the Blood-Brain Barrier in vivo and in vitro
R. N. Alyaudtin (2001)
Mechanisms of nucleotide trafficking during siRNA delivery to endothelial cells using perfluorocarbon nanoemulsions.
Megan M. Kaneda (2010)
Exploiting lipid raft transport with membrane targeted nanoparticles: a strategy for cytosolic drug delivery.
Kathryn Partlow (2008)
Platelet activation, atherothrombosis
G Davi (2007)
Ocular drug delivery by liposome-chitosan nanoparticle complexes (LCS-NP).
Y. Diebold (2007)
Albumin nanoparticles targeted with Apo E enter the CNS by transcytosis and are delivered to neurones.
Anja Zensi (2009)
Tumor-Targeted Gene Delivery Using Poly(Ethylene Glycol)-Modified Gelatin Nanoparticles: In Vitro and in Vivo Studies
Goldie Kaul (2005)
Optical Imaging of the Adoptive Transfer of Human Endothelial Cells in Mice Using Anti-Human CD31 Monoclonal Antibody
A. Bogdanov (2006)
Filamentous polymer nanocarriers of tunable stiffness that encapsulate the therapeutic enzyme catalase.
Eric A Simone (2009)
How to study dendriplexes II: Transfection and cytotoxicity.
D. Shcharbin (2010)
Design of imidazole-containing endosomolytic biopolymers for gene delivery.
D. Pack (2000)
Pegylated liposomal doxorubicin in ovarian cancer
R. Strother (2009)
Apolipoprotein A-I coating of protamine-oligonucleotide nanoparticles increases particle uptake and transcytosis in an in vitro model of the blood-brain barrier.
I. Kratzer (2007)
Renal vascular inflammation induced by Western diet in ApoE-null mice quantified by (19)F NMR of VCAM-1 targeted nanobeacons.
R. Southworth (2009)
Intravascular Delivery of Particulate Systems: Does Geometry Really Matter?
P. Decuzzi (2008)
Apolipoprotein-mediated Transport of Nanoparticle-bound Drugs Across the Blood-Brain Barrier
J. Kreuter (2002)
Cytotoxicity of nanoparticles.
Nastassja Lewinski (2008)
The role of nanoparticle size in hemocompatibility.
A. Mayer (2009)
Chloride Accumulation and Swelling in Endosomes Enhances DNA Transfer by Polyamine-DNA Polyplexes*
N. D. Sonawane (2003)
PAMAM dendrimers for brain delivery of therapeutics for the treatment of cerebral palsy: chemistry, in vivo efficacy, imaging
R Kannan (2009)
Clathrin-independent endocytosis: new insights into caveolae and non-caveolar lipid raft carriers.
M. Kirkham (2005)
PLATELET PHAGOCYTOSIS AND AGGREGATION
H. Movat (1965)
Vascular Targeting: Recent Advances and Therapeutic Perspectives
A. Hajitou (2006)
Immunoliposomes Directed Toward VCAM-1 Interact Specifically with Activated Endothelial Cells—A Potential Tool for Specific Drug Delivery
M. Voinea (2005)
Biomimetic glycoliposomes as nanocarriers for targeting P-selectin on activated platelets.
JunMin Zhu (2007)
Methotrexate loaded polyether-copolyester dendrimers for the treatment of gliomas: enhanced efficacy and intratumoral transport capability.
R. S. Dhanikula (2008)
Nanofabricated particles for engineered drug therapies: a preliminary biodistribution study of PRINT nanoparticles.
Stephanie E. A. Gratton (2007)
Endothelial alpha(v)beta3 integrin-targeted fumagillin nanoparticles inhibit angiogenesis in atherosclerosis.
P. Winter (2006)
Gene delivery targeted to the brain using an Angiopep-conjugated polyethyleneglycol-modified polyamidoamine dendrimer.
Weilun Ke (2009)
Nanoparticle-mediated drug delivery to tumor vasculature suppresses metastasis
E. Murphy (2008)
Vascular Endothelium in Inflamed Tissue as a Target for Site Selective Delivery of Drugs
M. Everts (2001)
Active targeting schemes for nanoparticle systems in cancer therapeutics.
J. D. Byrne (2008)
Recurrent epithelial ovarian carcinoma: a randomized phase III study of pegylated liposomal doxorubicin versus topotecan.
A. Gordon (2001)
Target specific intracellular delivery of siRNA/PEI-HA complex by receptor mediated endocytosis.
G. Jiang (2009)
In vitro study of the hemocompatibility of superparamagnetic contrast agent for magnetic resonance imaging.
C. Chouly (1994)
Cationic albumin conjugated pegylated nanoparticle with its transcytosis ability and little toxicity against blood-brain barrier.
W. Lu (2005)
Functionalized Micellar Systems for Cancer Targeted Drug Delivery
Damon M Sutton (2006)
In vitro and in vivo platelet targeting by cyclic RGD-modified liposomes.
R. Srinivasan (2010)
Polymerization of hydrogels inside self-assembled block copolymer vesicles.
Jeffery Gaspard (2009)
Nanoparticle‐induced platelet aggregation and vascular thrombosis
Anna Radomski (2005)
The adsorption of hyperbranched polymers on silicon oxide surfaces.
Sedat Ondaral (2006)
Role of erythrocytes in leukocyte-endothelial interactions: mathematical model and experimental validation.
L. Munn (1996)
Influence of erythrocyte aggregation on leukocyte margination in postcapillary venules of rat mesentery.
M. J. Pearson (2000)
Polymer vesicles in vivo: correlations with PEG molecular weight.
P. Photos (2003)
Vascular and cellular targeting for photodynamic therapy.
B. Chen (2006)
Endocytic mechanisms for targeted drug delivery.
Lisa Bareford (2007)
Surface charge of nanoparticles determines their endocytic and transcytotic pathway in polarized MDCK cells.
Oshrat Harush-Frenkel (2008)
Biodistribution of colloidal gold nanoparticles after intravenous administration: effect of particle size.
Ganeshchandra Sonavane (2008)
Leukocyte-inspired biodegradable particles that selectively and avidly adhere to inflamed endothelium in vitro and in vivo
Harshad S. Sakhalkar (2003)
PLGA nanoparticle--peptide conjugate effectively targets intercellular cell-adhesion molecule-1.
N. Zhang (2008)
Electrostatically mediated liposome fusion and lipid exchange with a nanoparticle-supported bilayer for control of surface charge, drug containment, and delivery.
J. Liu (2009)
Red blood cells augment leukocyte rolling in a virtual blood vessel.
C. Migliorini (2002)
Size and shape effects in the biodistribution of intravascularly injected particles.
P. Decuzzi (2010)
Delivery and efficacy of a cancer drug as a function of the bond to the gold nanoparticle surface.
Yu Cheng (2010)
Hydrodynamic interaction between erythrocytes and leukocytes affects rheology of blood in microvessels.
Vijay Pappu (2007)
Shaping nano-/micro-particles for enhanced vascular interaction in laminar flows.
Sei-Young Lee (2009)
Mechanisms of platelet activation: need for new strategies to protect against platelet-mediated atherothrombosis.
L. Jennings (2009)
Potential role of size and hemodynamics in the efficacy of vascular-targeted spherical drug carriers.
P. Charoenphol (2010)
Making polymeric micro- and nanoparticles of complex shapes
J. Champion (2007)
Conditions for the occurrence of large near-wall excesses of small particles during blood flow.
E. Eckstein (1988)
A biomimetic pH-responsive polymer directs endosomal release and intracellular delivery of an endocytosed antibody complex.
C. Lackey (2002)
Dendrimer-entrapped gold nanoparticles as a platform for cancer-cell targeting and imaging.
X. Shi (2007)
HUVEC take up opsonized zymosan particles and secrete cytokines IL-6 and IL-8 in vitro.
H. Langeggen (2003)
In vivo targeting of acoustically reflective liposomes for intravascular and transvascular ultrasonic enhancement.
S. Demos (1999)
Blood Compatibility of Cetyl Alcohol/Polysorbate-Based Nanoparticles
J. Koziara (2005)
Rheological properties of the blood influencing selectin-mediated adhesion of flowing leukocytes.
K. Abbitt (2003)
Understanding the nanoparticle–protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles
T. Cedervall (2007)
This paper is referenced by
The Future of Nanoparticle-Directed Venous Therapy.
B. Jacobs (2017)
Development of Long-Circulating pH-Sensitive Liposomes to Circumvent Gemcitabine Resistance in Pancreatic Cancer Cells
H. Xu (2016)
The margination propensity of ellipsoidal micro/nanoparticles to the endothelium in human blood flow.
A. Thompson (2013)
ICP-MS analysis of lanthanide-doped nanoparticles as a non-radiative, multiplex approach to quantify biodistribution and blood clearance.
S. Crayton (2012)
Targeting therapeutics to the vascular wall in atherosclerosis--carrier size matters.
P. Charoenphol (2011)
Immunoliposomes: A review on functionalization strategies and targets for drug delivery.
Josimar O. Eloy (2017)
Development of High-Content Gemcitabine PEGylated Liposomes and Their Cytotoxicity on Drug-Resistant Pancreatic Tumour Cells
H. Xu (2014)
Vascular Targeting of Nanocarriers: Perplexing Aspects of the Seemingly Straightforward Paradigm
Melissa D. Howard (2014)
Molecular interaction of proteins and peptides with nanoparticles.
A. Shemetov (2012)
Structural and functional aspects of the interaction of proteins and peptides with nanoparticles
K. A. Rumyantsev (2013)
Non-invasive Parenchymal, Vascular and Metabolic High-frequency Ultrasound and Photoacoustic Rat Deep Brain Imaging
P. Giustetto (2015)
Polymeric Nanostructures for Imaging and Therapy.
Mahmoud Elsabahy (2015)
Heteromultivalent liposomal nanoconstructs for enhanced targeting and shear-stable binding to active platelets for site-selective vascular drug delivery.
Christa L. Modery (2011)
Non-affinity factors modulating vascular targeting of nano- and microcarriers.
J. Myerson (2016)